Ko Takigami - Concepedia

Author

Ko Takigami

Beth Israel Deaconess Medical Center

Also Known As

K Takigami, K. Takigami, Ko Takigami

Publications

Citations

H-Index

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Harvard University Massachusetts Institute of Technology Massachusetts General Hospital Asahikawa Medical College Hospital

About

Ko Takigami is an author at Beth Israel Deaconess Medical Center specializing in medicine, xenotransplantation, and cardiac xenotransplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	861
2	Cell Biology	3	3	63
3	Cellular Therapies	2	2	39
4	Allergy	1	1	69
5	Cellular Physiology	1	1	24

Ko Takigami

Publications

995

Citations

H-Index

Page 1

	Year	Citations
Expression of heme oxygenase-1 can determine cardiac xenograft survival Miguel P. Soares, Y. Lin, Josef Anrather, Nature Medicine Cardiovascular DiseaseHeme DegradationPhysiologyCardiac XenotransplantationRedox Biology	1998	614
Complement-Fixing Elicited Antibodies Are a Major Component in the Pathogenesis of Xenograft Rejection T Miyatake, Koichiro Sato, Ko Takigami, The Journal of Immunology ImmunologyPathologyMolecular PharmacologyMajor ComponentDisease Pathophysiology	1998	75
Accommodated Xenografts Survive in the Presence of Anti-Donor Antibodies and Complement That Precipitate Rejection of Naive Xenografts Yuan Lin, Miguel P. Soares, Koichiro Sato, The Journal of Immunology ImmunologyIgm AbsHamster HeartsImmunotherapyCardiac Xenotransplantation	1999	69
RECOMBINANT ADENOVIRAL MEDIATED CD39 GENE TRANSFER PROLONGS CARDIAC XENOGRAFT SURVIVAL1 Masato Imai, Ko Takigami, Olaf Guckelberger, Transplantation	2000	64
Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection. Masato Imai, Ko Takigami, Olaf Guckelberger, PubMed	1999	48
Modulation of Nucleotide Triphosphate Diphosphohydrolase-1 (NTPDase-1)/cd39 in Xenograft Rejection Masato Imai, Ko Takigami, Olaf Guckelberger, Molecular Medicine XenotransplantationCellular EnzymologyOligonucleotideMolecular BiologyBiochemical Genetics	1999	40
Rejection of Cardiac Xenografts by CD4+ or CD8+ T Cells Yuan Lin, Miguel P. Soares, Koichiro Sato, The Journal of Immunology Cardiac MuscleCell TherapyHeart FailureImmunologyImmune Regulation	1999	28
CD39/vascular ATP diphosphohydrolase modulates xenograft survival Masato Imai, Ko Takigami, Olaf Guckelberger, Transplantation Proceedings Cd39/vascular Atp DiphosphohydrolasePhysiologyEndothelial DysfunctionCell DeathVascular Biology	2000	24
SUPPRESSION OF DELAYED XENOGRAFT REJECTION BY SPECIFIC DEPLETION OF ELICITED ANTIBODIES OF THE IgM ISOTYPE1 Koichiro Sato, Ko Takigami, T Miyatake, Transplantation	1999	22
Pathogenesis of and potential therapies for delayed xenograft rejection Miguel P. Soares, Yuan Lin, Koichiro Sato, Current Opinion in Organ Transplantation Cell TherapyImmunologyTransplantation MedicineImmunotherapyCardiac Xenotransplantation	1999	11

Page 1